Dopaminergic receptors: A new antihypertensive mechanism
Abstract:
The neurotransmitter dopamine, precursor of noradrenaline, induces a variety of cardiovascular and renal physiological responses, including an increase in myocardial contractility and cardiac output without changes in heart rate, passive and active vasodilatation, diuresis and natriuresis. These responses result from its interaction with the dopamine receptors D<inf>1</inf>, D<inf>2</inf>, D<inf>3</inf>, D<inf>4</inf> and D<inf>5</inf>. In addition, recent findings suggest the existence of D<inf>6</inf> and D<inf>7</inf> receptors. In some types of hypertension dopamine is known to influence the control of arterial pressure by influencing the central and peripheral nervous system and target organs such as the kidneys and adrenal glands. Since dopamine and its derivatives have been shown to have antihypertensive effects, it is important to review the physiological and pharmacological aspects of dopamine and its receptors, and the clinical uses that they could have in the therapy of arterial hypertension. © 2002 Lippincott Williams & Wilkins.
Año de publicación:
2002
Keywords:
- dopamine
- Dopamine agonist
- dopamine receptor
- Hypertension
- Kidney
Fuente:
scopusTipo de documento:
Other
Estado:
Acceso restringido
Áreas de conocimiento:
- Hipertensión
- Medicina interna
- Medicina interna
Áreas temáticas de Dewey:
- Farmacología y terapéutica
- Enfermedades
- Fisiología humana
Objetivos de Desarrollo Sostenible:
- ODS 3: Salud y bienestar
- ODS 17: Alianzas para lograr los objetivos
- ODS 2: Hambre cero